Pacific Biosciences of California (PACB) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Pacific Biosciences of California Revenue Highlights


Latest Revenue (Y)

$160.00M

Latest Revenue (Q)

$38.44M

Main Segment (Y)

Product

Main Geography (Y)

Americas

Pacific Biosciences of California Revenue by Period


Pacific Biosciences of California Revenue by Year

DateRevenueChange
2025-12-31$160.00M3.89%
2024-12-31$154.01M-23.19%
2023-12-31$200.52M56.29%
2022-12-31$128.30M-1.69%
2021-12-31$130.51M65.43%
2020-12-31$78.89M-13.20%
2019-12-31$90.89M15.60%
2018-12-31$78.63M-15.88%
2017-12-31$93.47M3.04%
2016-12-31$90.71M-2.23%
2015-12-31$92.78M53.12%
2014-12-31$60.59M115.02%
2013-12-31$28.18M8.46%
2012-12-31$25.98M-23.27%
2011-12-31$33.86M1922.88%
2010-12-31$1.67M1140.00%
2009-12-31$135.00K-85.02%
2008-12-31$901.00K-58.34%
2007-12-31$2.16M-

Pacific Biosciences of California generated $160.00M in revenue during NA 2025, up 3.89% compared to the previous quarter, and up 202.81% compared to the same period a year ago.

Pacific Biosciences of California Revenue by Quarter

DateRevenueChange
2025-09-30$38.44M-3.33%
2025-06-30$39.77M7.03%
2025-03-31$37.15M-5.28%
2024-12-31$39.22M-1.86%
2024-09-30$39.97M10.98%
2024-06-30$36.01M-7.21%
2024-03-31$38.81M-33.50%
2023-12-31$58.36M4.79%
2023-09-30$55.69M17.06%
2023-06-30$47.57M22.30%
2023-03-31$38.90M42.21%
2022-12-31$27.35M-15.34%
2022-09-30$32.31M-8.90%
2022-06-30$35.47M6.92%
2022-03-31$33.17M-7.90%
2021-12-31$36.02M3.24%
2021-09-30$34.89M13.97%
2021-06-30$30.61M5.56%
2021-03-31$29.00M6.86%
2020-12-31$27.14M42.21%
2020-09-30$19.08M11.74%
2020-06-30$17.08M9.48%
2020-03-31$15.60M-44.15%
2019-12-31$27.93M27.45%
2019-09-30$21.91M-10.99%
2019-06-30$24.62M49.90%
2019-03-31$16.43M-15.88%
2018-12-31$19.53M7.52%
2018-09-30$18.16M-15.84%
2018-06-30$21.58M11.45%
2018-03-31$19.36M-22.35%
2017-12-31$24.93M5.90%
2017-09-30$23.55M17.30%
2017-06-30$20.07M-19.43%
2017-03-31$24.91M-3.14%
2016-12-31$25.72M2.40%
2016-09-30$25.12M21.07%
2016-06-30$20.75M8.47%
2016-03-31$19.13M-47.28%
2015-12-31$36.28M160.70%
2015-09-30$13.92M-44.20%
2015-06-30$24.94M41.34%
2015-03-31$17.64M4.38%
2014-12-31$16.90M-18.03%
2014-09-30$20.62M80.51%
2014-06-30$11.43M-1.86%
2014-03-31$11.64M27.47%
2013-12-31$9.13M23.07%
2013-09-30$7.42M22.70%
2013-06-30$6.05M8.43%
2013-03-31$5.58M-5.10%
2012-12-31$5.88M111.74%
2012-09-30$2.78M-61.93%
2012-06-30$7.29M-27.37%
2012-03-31$10.04M-19.33%
2011-12-31$12.44M18.30%
2011-09-30$10.52M-1.04%
2011-06-30$10.63M3837.04%
2011-03-31$270.00K-3.57%
2010-12-31$280.00K27.27%
2010-09-30$220.00K-65.02%
2010-06-30$629.00K15.41%
2010-03-31$545.00K303.70%
2009-12-31$135.00K100.00%
2009-09-30--

Pacific Biosciences of California generated $38.44M in revenue during Q3 2025, up -3.33% compared to the previous quarter, and up 106.74% compared to the same period a year ago.

Pacific Biosciences of California Revenue Breakdown


Pacific Biosciences of California Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 22Dec 21Dec 20
Instrument$53.82M$65.78M$48.72M$61.32M$34.28M
Consumable$81.94M$70.37M$59.98M$52.18M$31.14M
Product$135.76M$136.15M$108.70M$113.50M$65.42M
Service And Other$24.25M$17.86M$19.61M$17.01M$13.47M

Pacific Biosciences of California's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (45.90%), Consumable (27.70%), Instrument (18.20%), and Service And Other (8.20%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20
Consumable$21.63M$21.28M$18.93M$20.10M$35.88M$18.51M$15.98M$16.87M$13.73M$13.95M$16.07M$14.56M$12.69M$37.19M$12.25M$10.36M$8.02M$4.82M--
Service And Other$5.68M$5.84M$6.68M$6.04M$9.39M$4.67M$3.80M$4.13M$3.92M$4.25M$4.58M$4.80M$5.29M$4.93M$4.38M$4.08M$3.69M$3.51M$3.33M$3.32M
Product$38.97M$32.60M$33.08M$31.11M$65.84M$35.30M$35.01M$51.56M$43.66M$34.65M$22.77M$27.51M$30.18M$28.24M$30.50M$26.53M$25.30M$23.63M$15.75M$13.76M
Instrument$17.34M$11.32M$14.15M$11.02M$29.96M$16.79M$19.02M$34.69M$29.92M$20.70M$11.44M$15.62M$15.55M$45.15M$14.28M$14.94M$7.73M$8.93M--

Pacific Biosciences of California's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (46.60%), Consumable (25.87%), Instrument (20.73%), and Service And Other (6.79%).

Pacific Biosciences of California Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24Dec 22Dec 21Dec 20
EMEA$44.05M$34.59M---
UNITED STATES$69.70M$75.30M---
Americas$72.80M$78.71M---
Asia Pacific$43.16M$40.71M$36.15M$35.72M$22.55M
North America--$69.56M$64.52M$37.28M
Europe--$22.60M$30.27M$19.07M

Pacific Biosciences of California's latest annual revenue breakdown by geography, as of Dec 25: Americas (31.69%), UNITED STATES (30.34%), EMEA (19.18%), and Asia Pacific (18.79%).

Quarterly Revenue by Country

CountryDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Sep 23Jun 23Mar 23Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Sep 20Jun 20Mar 20Sep 19
Asia Pacific$9.34M$9.59M$12.61M$11.61M$17.19M$10.74M$12.78M$15.72M$12.88M$11.96M$9.57M$8.01M$8.39M$9.17M$9.77M$8.52M$5.77M$4.43M$4.44M$6.58M
EMEA$14.59M$10.75M$9.47M$9.24M$17.12M$9.12M$8.36M$10.99M$10.73M$7.87M----------
Americas$20.71M$18.10M$17.69M$16.30M$40.93M$20.11M$17.68M$28.98M$23.96M$19.07M----------
North America----------$16.74M$21.72M$19.08M$19.37M$14.35M$12.16M$8.97M$8.46M$7.76M$10.39M
Europe----------$6.00M$5.74M$5.70M$6.35M$6.49M$8.32M$4.34M$4.19M$3.40M$4.94M

Pacific Biosciences of California's latest quarterly revenue breakdown by geography, as of Dec 25: Americas (46.39%), EMEA (32.68%), and Asia Pacific (20.93%).

Pacific Biosciences of California Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
IARTIntegra LifeSciences$1.64B$402.06M
AVNSAvanos Medical$701.20M$177.80M
POMPOMDOCTOR$342.56M-
FLGTFulgent Genetics$322.67M$84.07M
IOVAIovance Biotherapeutics$263.50M$67.45M
SIBNSI-BONE$200.93M$48.66M
DNAGinkgo Bioworks$170.16M$49.60M
PACBPacific Biosciences of California$160.00M$38.44M
BFLYButterfly Network$97.61M$21.49M
DRIODarioHealth$27.04M$5.01M
OFIXOrthofix Medical-$205.63M

PACB Revenue FAQ


What is Pacific Biosciences of California’s yearly revenue?

Pacific Biosciences of California's yearly revenue for 2025 was $160M, representing an increase of 3.89% compared to 2024. The company's yearly revenue for 2024 was $154.01M, representing a decrease of -23.19% compared to 2023. PACB's yearly revenue for 2023 was $200.52M, representing an increase of 56.29% compared to 2022.

What is Pacific Biosciences of California’s quarterly revenue?

Pacific Biosciences of California's quarterly revenue for Q3 2025 was $38.44M, a -3.33% decrease from the previous quarter (Q2 2025), and a -3.82% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $39.77M, a 7.03% increase from the previous quarter (Q1 2025), and a 10.42% increase year-over-year (Q2 2024). PACB's quarterly revenue for Q1 2025 was $37.15M, a -5.28% decrease from the previous quarter (Q4 2024), and a -4.27% decrease year-over-year (Q1 2024).

What is Pacific Biosciences of California’s revenue growth rate?

Pacific Biosciences of California's revenue growth rate for the last 3 years (2023-2025) was -20.21%, and for the last 5 years (2021-2025) was 22.60%.

What are Pacific Biosciences of California’s revenue streams?

Pacific Biosciences of California's revenue streams in c 25 are Instrument, Consumable, Product, and Service And Other. Instrument generated $53.82M in revenue, accounting 18.20% of the company's total revenue, down -18.18% year-over-year. Consumable generated $81.94M in revenue, accounting 27.70% of the company's total revenue, up 16.44% year-over-year. Product generated $135.76M in revenue, accounting 45.90% of the company's total revenue, down -0.29% year-over-year. Service And Other generated $24.25M in revenue, accounting 8.20% of the company's total revenue, up 35.72% year-over-year.

What is Pacific Biosciences of California’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Pacific Biosciences of California was Product. This segment made a revenue of $135.76M, representing 45.90% of the company's total revenue.